Dopaminergic agonists in the treatment of Parkinson's disease

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017

Charcot, hysteria, and simulated disorders.

Handbook of clinical neurology·2016

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

European journal of neurology·2014

Continuous in-home monitoring of essential tremor.

Parkinsonism & related disorders·2013

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

European journal of neurology·2013

Historical underpinnings of the term essential tremor in the late 19th century.

Neurology·2008

Developing Interim Outcome Measures for Multi-Arm Multistage Clinical Trials in Multiple Sclerosis.

Neurology·2026

Sustained Benefits of a Multidomain Lifestyle Intervention in Multiple Sclerosis in the LIMS Study: A 24-Month Follow-Up.

Neurology·2026

Stroke in the Young: Incidence, 30-Day Case Fatality Rates, and Risk Factors Over Time in a Population-Based Study.

Neurology·2026

Long-Term Risk of Dementia After TIA: A Population-Wide Matched Cohort Study.

Neurology·2026

Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.

Neurology·2026

Diagnostic Yield and Therapeutic Impact of Etiologic Investigations After Status Epilepticus: Insights From the ICTAL Registry.

Neurology·2026

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

The Annals of pharmacotherapy·2026

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Journal of opioid management·2026

Phospholipases D: An Update on Structure-Function Relationships.

Methods in molecular biology (Clifton, N.J.)·2026

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Alcohol (Fayetteville, N.Y.)·2026

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Molecular pain·2026

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

CNS drugs·2026

Related Experiment Videos

Dopaminergic agonists in the treatment of Parkinson's disease

Related Concept Videos

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Charcot, hysteria, and simulated disorders.

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

Continuous in-home monitoring of essential tremor.

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

Historical underpinnings of the term essential tremor in the late 19th century.

Developing Interim Outcome Measures for Multi-Arm Multistage Clinical Trials in Multiple Sclerosis.

Sustained Benefits of a Multidomain Lifestyle Intervention in Multiple Sclerosis in the LIMS Study: A 24-Month Follow-Up.

Stroke in the Young: Incidence, 30-Day Case Fatality Rates, and Risk Factors Over Time in a Population-Based Study.

Long-Term Risk of Dementia After TIA: A Population-Wide Matched Cohort Study.

Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.

Diagnostic Yield and Therapeutic Impact of Etiologic Investigations After Status Epilepticus: Insights From the ICTAL Registry.

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Phospholipases D: An Update on Structure-Function Relationships.

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Related Experiment Videos

Dopaminergic agonists in the treatment of Parkinson's disease

Related Concept Videos

Related Articles